Embeda® is a prescription medication that combines morphine sulfate with naltrexone hydrochloride, designed to provide pain relief while also incorporating features to deter abuse. It’s particularly aimed at patients who need continuous, long-term pain management for which alternative treatments are not sufficient. The Drug Formulary Commission of Massachusetts is currently reviewing Embeda® for potential inclusion in its list of approved medications, highlighting its status as the only abuse-deterrent formulation of extended-release morphine sulfate that has received approval from the U.S. Food and Drug Administration (FDA).
This medication was first approved by the FDA in 2009. However, it faced a setback in 2011 when it was voluntarily recalled due to stability concerns related to its manufacturing process. These issues were subsequently addressed, leading to FDA approval of a revised manufacturing process in 2013 and recognition of its abuse-deterrent properties in 2014. This made Embeda® the first among morphine extended-release products to achieve such designation.
The innovative aspect of Embeda® lies in its design: the capsules contain pellets of morphine sulfate with a core of naltrexone hydrochloride, at a ratio of 100:4.1. Morphine sulfate acts as a potent pain reliever by targeting the µ-receptor, which is primarily responsible for the drug’s analgesic effects. Naltrexone, on the other hand, is an opioid antagonist that counteracts the effects of opioids. This combination is fundamental for the drug’s abuse-deterrent feature; if the capsules are crushed, chewed or dissolved—a common method employed by individuals seeking to abuse opioid medication—the naltrexone is released. This can reverse the effects of morphine, potentially causing withdrawal symptoms in individuals who are opioid-tolerant and increasing the risk of overdose and death.
Clinical studies have supported Embeda®’s effectiveness in pain management and its relative safety. Furthermore, research has shown that when Embeda® is manipulated to release its contents, it is “less preferred” for abuse compared to other formulations of morphine intended for extended release. This indicates its potential to deter abuse through non-oral routes, such as snorting or injecting, which are common methods for achieving a more intense high.
Despite these safeguards, Embeda® like all opioid medications, carries significant risks. It is classified as a Schedule II controlled substance, reflecting its high potential for addiction, abuse and misuse—even when used as prescribed. The drug also carries a black box warning, the FDA’s most stringent caution, highlighting risks including addiction, abuse, misuse, life-threatening respiratory depression (severe breathing problems), accidental ingestion, neonatal opioid withdrawal syndrome (withdrawal symptoms in newborns) and dangerous interactions with alcohol.
Founded in 2008, WeDoRecover has evolved from an advisory service for addiction treatment into a comprehensive provider of care, following its 2019 merger with Changes Addiction Rehab in Johannesburg. Specialising in connecting patients to top-tier addiction treatment centers in the UK, South Africa and Thailand, WeDoRecover supports individuals globally, including those from the United Arab Emirates and Europe. Accepting both South African medical aid and international health insurance our organisation facilitates access to high-quality treatment for substance and alcohol use disorders, offering individualised care that addresses the physical, mental and social needs of patients.
Our team, led by Gareth Carter, offers empathetic and professional support, guiding you through every step of the treatment process. Whether you're in South Africa or abroad, our acceptance of various insurance plans makes quality care accessible, providing a platform for lasting recovery and a healthier future.
Inpatient Rehab
Rehab care is a good option if you are at risk of experiencing strong withdrawal symptoms when you try stop a substance. This option would also be recommended if you have experienced recurrent relapses or if you have tried a less-intensive treatment without success.
Outpatient
If you're committed to your sobriety but cannot take a break from your daily duties for an inpatient program. Outpatient rehab treatment might suit you well if you are looking for a less restricted format for addiction treatment or simply need help with mental health.
Therapy
Therapy can be good step towards healing and self-discovery. If you need support without disrupting your routine, therapy offers a flexible solution for anyone wishing to enhance their mental well-being or work through personal issues in a supportive, confidential environment.
Mental Health
Are you having persistent feelings of being swamped, sad or have sudden surges of anger or intense emotional outbursts? These are warning signs of unresolved trauma mental health. A simple assesment by a mental health expert could provide valuable insights into your recovery.
Finding the right rehab close to you is simple with WeDoRecover. Our network includes the finest rehab centers, ensuring personalised, quality care for your recovery needs. Let Gareth Carter and our empathetic team help guide you to a center that feels right for you, offering expert care and support. Start your healing today by choosing a rehab that's not just close to you, but also that truly cares about your loved ones recovery.